Fourth, tumor cells utilize several strategies to escape immune recognition, including the alteration or loss of MHC/HLA class I molecules, leading to the inability of CD8+ cytotoxic T cells (CTLs) to attack them (13). The gene discussed is HLA-C; the disease is neoplasm.